NEWALR&D LTD
ActiveKey figures
Ratios
2024/25Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: NEWALR&D LTD
What kind of company is it?
NEWALR&D LTD is a private limited company registered with Companies House under company number 09243410. It was incorporated on 1 Oct 2014. Its status is active. The registered office is in London (WC2H). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Turnover was £0. Loss for the year was £214,688. Net assets were £10,079,320, up 12.3% on the previous year. Cash at bank and in hand was £353. Total assets were £10,100,353 and total liabilities £21,033. The company had an average of 0 employees. Figures are available for 4 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By turnover it ranks lower than 93% of the 146 that publish turnover (median £2,577,327). By net assets it ranks higher than 95% of them (median £20,587). By total assets it ranks higher than 92% of them (median £124,497). By cash it ranks lower than 93% of them (median £101,426). By number of employees it ranks lower than 65% of them (median 1). It is older than 80% of them (median age 5.4 years).
Who runs and controls the company?
The company has 2 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 28 Oct 2027.
Control structure
Mr Donald Rupert Holms is the only person with significant control on record for this company; the PSC register shows no further links.
Filed accounts2019/20–2024/25
| 2019/20 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Turnover | — | 0 | 0 | 0 |
| Profit for the year | — | -135,056 | -66,831 | -214,688 |
| Cash at bank and in hand | 2 | 11,846 | 838 | 353 |
| Total assets | — | 7,011,846 | 9,000,838 | 10,100,353 |
| Total liabilities | — | 4,000 | 25,872 | 21,033 |
| Net assets / total equity | 2 | 7,007,846 | 8,974,966 | 10,079,320 |
| Average number of employees | — | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Ezrin peptide pharmaceutical product development
As described in the company's latest filed accounts.
History
13 events- Financial year 2024/25 endedAccounts: turnover £0, net assets £10.1m, 0 employees
- Financial year 2023/24 endedAccounts: turnover £0, net assets £9m, 0 employees
- Financial year 2022/23 endedAccounts: turnover £0, net assets £7m, 0 employees
- John ABELES appointedDirector
- Financial year 2019/20 endedAccounts: net assets £2
- Mr Donald Rupert Holms registered as a person with significant control
- Rupert Donald HOLMS resignedSecretary
- Rupert Donald HOLMS resignedDirector
Earlier events (5)
- Donald Rupert HOLMS appointedSecretary
- Donald Rupert HOLMS appointedDirector
- Rupert Donald HOLMS appointedSecretary
- Rupert Donald HOLMS appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.